Analytical Data
-
Gene name
UBL4B
- Application
-
Alternative Names
UBL4B; Ubiquitin-like Protein 4B
-
Species
Human
-
Source
E. coli
-
Tag
His tag N-Terminus
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q8N7F7
-
Expression Region
1-174 aa
-
AA Sequence
MFLTVKLLLG QRCSLKVSGQ ESVATLKRLV SRRLKVPEEQ QHLLFRGQLL EDDKHLSDYC IGPNASINVI MQPLEKMALK EAHQPQTQPL WHQLGLVLAK HFEPQDAKAV LQLLRQEHEE RLQKISLEHL EQLAQYLLAE EPHVEPAGER ELEAKARPQS SCDMEEKEEA AADQ
-
Molecular Weight
19.9 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
UBL4B, or Ubiquitin-like 4B, is a protein that has garnered significant attention in the field of cellular biology due to its involvement in various cellular processes, including protein stability, cell cycle regulation, and responses to stress conditions. Emerging research suggests that UBL4B plays a crucial role in the ubiquitin-proteasome system, a vital pathway for intracellular protein degradation and homeostasis. Abnormalities in this system are linked to several diseases, including cancers and neurodegenerative disorders, making UBL4B a promising target for therapeutic interventions. Studies have indicated that UBL4B is involved in the regulation of certain tumor suppressors and oncogenes, which positions it as a key player in cancer biology. Moreover, its potential role in the modulation of immune responses is an area of growing interest, particularly in the context of autoimmune diseases and infections. Recent advances in recombinant protein technology have enabled the production and characterization of UBL4B, facilitating further investigation into its molecular mechanisms and interactions within cellular pathways. Understanding the function of UBL4B at a deeper level may provide insights into its potential as a biomarker or a therapeutic target, paving the way for innovative treatments that leverage its unique properties and roles in health and disease.
